Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rogaratinib phase 2-3 antitumor study (Japan)
jRCT2080223933Phase 3Completed
- Start
- Jun 2018
- Modality
- Small Molecules
01
Overview
Phase 3 trial of rogaratinib in cancer (2 arms). Started Jun 2018; status: completed.
02
Drugs
rogaratinib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223933.